{Reference Type}: Case Reports
{Title}: Perimenstrual asthma: Report of a case with therapeutic intervention of oral prednisone.
{Author}: Lei Z;Yanhan D;Yi W;Shengdao X;Weining X;
{Journal}: J Asthma
{Volume}: 55
{Issue}: 12
{Year}: 12 2018
暂无{DOI}: 10.1080/02770903.2017.1418886
{Abstract}: Many asthmatic women of childbearing age experience cyclical aggravation of asthmatic symptoms during the perimenstrual period, or perimenstrual asthma (PMA). PMA is considered to be a difficult-to-treat asthma phenotype; conventional asthma therapies are not always effective against PMA.
We report a case of a 27-year-old female with PMA who had received standard asthma treatment since 2013.
The patient showed a dramatic response to therapeutic intervention of oral prednisone, taken for 7 days prior to menstruation each month, in a dose-dependent manner.
Premenstrual treatment with oral prednisone may be a successful new direction for the treatment of PMA, a troublesome type of asthma.